Autopsy report · NCT00319683

A Study of ADH300004 and 5-Fluorouracil in Locally Advanced, Recurrent, or Metastatic Hepatocellular Carcinoma

Cause of deathFunding or business Automatic label, confidence 0.9, unverified. How labels are made.

“Lack of funds”

The sponsor’s own words in the registry.

Life of this trial

No results are posted on the registry.

Vital statistics

Status: Terminated
Phase: Phase 1, Phase 2
Sponsor: Adherex Technologies, Inc.
Sponsor type: Industry
Conditions: Hepatocellular Carcinoma
Interventions: ADH300004
Sites: 7
Countries: Singapore, Taiwan, United States

Trials that died the same way

Early Systemic Central Nervous System Prophylaxis in Diffuse Large B-cell Lymphoma
“lack of funding” (89% match in meaning)

Look deeper

The official registry record (the source of truth)
Record history: every change the sponsor made
Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.